PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Gensco Pharma

Press Release

Share      Blog

Receive press releases from Gensco Pharma: By Email PDF Version RSS Feeds:

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds


Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications.

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds
Miami, FL, November 19, 2016 --(PR.com)-- Gensco Pharma announces Astero®, a FDA approved prescription hydrogel which contains the topical anesthetic lidocaine hydrochloride.

Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications including opiate based drugs. “Astero® provides the clinician a proven and trusted first line wound dressing for ulcerations, first and second degree burns, post-surgical incisions, cuts and abrasions. The soothing hydrogel creates a superior wound healing environment while the lidocaine component imparts sustained pain control of the wound,” says Dr. Brenner. “Since our inception, our corporate focus is to utilize our resources on innovative research and the development of unique delivery systems to improve access to products providing improved quality of life for patients who suffer from pain and debilitating diseases,” said Carlos Alfaras, CEO of Gensco Pharma. “Our blend of science and understanding of the value proposition to patients and industry partners drives us to develop improved outcomes for all. Astero is a perfect example of Gensco Pharma at work, including the clinical perspective and the ability to assist with the financial burden to patients with our copay assistance programs.”

Astero® is offered through national wholesalers, chain pharmacies and Group Purchasing Organizations including but not limited to: McKesson, Cardinal, AmerisourceBergen, HD Smith, Walgreens, CVS, Intalere, Innovatix and MedAssets.

For more information on Astero®, visit www.asterogel.com.
Contact Information
Gensco Pharma
Randi Aileen Press
704-799-5184
Contact
www.genscopharma.com

Click here to view the list of recent Press Releases from Gensco Pharma
Promote Your Business